Clinical Trials Browser

Recruiting × Sorafenib × Genitourinary × Clear all

NCT06690697 2024-11-15

Combination of Toripalimab and JS004 Therapy for ccRCC

Phase 2 Recruiting

Carcinoma, Renal Cell